tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
Holding SAGE?
Track your performance easily

SAGE Therapeutics (SAGE) Income Statement

896 Followers

SAGE Therapeutics Income Statement

Last quarter (Q3 2024), SAGE Therapeutics's total revenue was $11.87M, an increase of 260.38% from the same quarter last year. In Q3, SAGE Therapeutics's net income was $-93.55M. See SAGE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.71M$ 86.45M$ 7.69M$ 6.31M$ 1.11B$ 6.87M
Cost of Revenue
$ 1.11M-$ 813.00K-$ 565.00K-
Gross Profit
$ 25.71M$ 86.45M$ 6.87M$ 6.31M$ 1.11B$ 6.87M
Operating Expense
$ 620.52M$ 666.30M$ 553.86M$ 467.22M$ 517.97M$ 714.99M
Operating Income
$ -594.81M$ -579.85M$ -546.99M$ -460.91M$ 596.23M$ -708.12M
Net Non Operating Interest Income Expense
$ 36.52M$ 38.74M$ 14.19M$ 2.88M$ 9.60M$ 27.80M
Other Income Expense
$ 72.00K$ 383.00K$ 15.00K$ -134.00K$ -250.00K$ -82.00K
Pretax Income
$ -550.57M$ -539.33M$ -532.78M$ -456.79M$ 607.20M$ -679.44M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -556.75M$ -539.33M$ -531.97M$ -457.89M$ 606.07M$ -679.44M
Basic EPS
$ -9.28$ -9.05$ -8.98$ -7.80$ 11.66$ -13.38
Diluted EPS
$ -9.28$ -9.05$ -8.98$ -7.80$ 11.43$ -13.38
Basic Average Shares
$ 241.34M$ 59.84M$ 59.31M$ 58.67M$ 51.98M$ 50.83M
Diluted Average Shares
$ 241.34M$ 59.84M$ 59.31M$ 58.67M$ 53.00M$ 50.83M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 620.52M$ 666.30M$ -553.86M$ 467.22M$ 517.97M$ 714.99M
Net Income From Continuing And Discontinued Operation
$ -558.36M$ -541.49M$ -532.78M$ -457.89M$ 606.07M$ -680.24M
Normalized Income
$ -312.08M-----
Interest Expense
------
EBIT
$ -558.36M$ -541.49M$ -532.78M$ -456.79M$ 623.97M$ -679.44M
EBITDA
$ -557.13M$ -540.09M$ -531.68M$ -452.59M$ 626.60M$ -677.14M
Currency in USD

SAGE Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis